Skip to main content

Rapid Nutrition Showcases HealthTech Strategy on Bloomberg Television

Written by Customer Service on . Posted in Public Companies.

Interview showcases the Company’s implementation of intelligent technologies across consumer wellness and investor engagement, reinforcing its evolution into a scalable HealthTech platform

LONDON, July 06, 2026 (GLOBE NEWSWIRE) — Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech company combining evidence-based nutrition with intelligent technologies, has been featured on Bloomberg Television, where Managing Director Simon St Ledger discussed the Company’s implementation of intelligent technologies and its vision for the future of personalized consumer health.

The interview highlighted Rapid Nutrition’s practical implementation of intelligent technologies designed to enhance consumer engagement by combining the Company’s proprietary nutritional knowledge, practitioner-informed wellness frameworks and educational resources to deliver more personalized, context-aware experiences at scale.

Rather than viewing artificial intelligence as a standalone initiative, Rapid Nutrition is embedding these capabilities across its broader HealthTech strategy to strengthen consumer education, personalized product guidance, investor communications and operational efficiency. Management believes the convergence of intelligent technologies, practitioner expertise and evidence-based nutrition represents an important evolution in how consumers engage with wellness brands.

These capabilities are expected to complement Rapid Nutrition’s expanding retail operations by providing consumers with consistent educational resources and personalized product information while supporting retail teams with immediate access to structured wellness knowledge across both digital and physical environments.

Rapid Nutrition’s technology strategy is underpinned by its broader commitment to evidence-based wellness, including participation in the ongoing U.S.–Australia TOPS osteoarthritis and joint health study involving women over 50, where SystemLS forms part of the broader wellness framework. The Company believes the integration of technology, clinical collaboration and practitioner expertise provides a differentiated platform for long-term growth.

Managing Director Simon St Ledger commented:

“Artificial intelligence is becoming part of everyday business, but we believe long-term value comes from practical implementation rather than simply adopting new technology. At Rapid Nutrition, we are integrating intelligent technologies across our consumer wellness and investor engagement platforms by combining decades of proprietary nutritional knowledge, practitioner expertise and clinically informed wellness frameworks to deliver more personalized experiences at scale. Bloomberg provided an opportunity to discuss how Rapid Nutrition is translating emerging technologies into practical consumer and investor applications, supporting our long-term vision of building a scalable HealthTech platform.”

The Bloomberg interview provided an opportunity to showcase Rapid Nutrition’s continued execution of its long-term HealthTech strategy and the practical implementation of intelligent technologies across consumer wellness and investor engagement.

The interview is available via the Company’s website and investor relations channels.

About Rapid Nutrition

Rapid Nutrition PLC is a global HealthTech company advancing wellness through evidence-based, personalized nutrition solutions. By leveraging artificial intelligence, advanced technologies, and clinical research, the company delivers products and programs designed to optimize nutrition, improve health outcomes, and promote sustainable, healthier lifestyles worldwide.

Investor Relations Contact:

ir@rnplc.com

Investor Access (24/7 AI Platform)

+1 (855) 77-ALRPD

Cautionary Statement Regarding Forward-Looking Statements

This announcement contains forward-looking statements, including statements regarding the Company’s strategy, market opportunities, industry trends, product development activities, clinical research initiatives and future business prospects. Forward-looking statements are based on management’s current expectations, assumptions and beliefs and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements.

Forward-looking statements speak only as of the date of this announcement and should not be regarded as a representation that future plans, expectations or objectives will be achieved. Except as required by applicable law or regulation, Rapid Nutrition PLC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are provided for illustrative purposes only and are not guarantees of future performance.

Market Abuse Regulation
This announcement has been prepared in accordance with the Company’s disclosure obligations under applicable market abuse and market disclosure regulations. The Company does not consider the information contained in this announcement to constitute inside information at the time of publication.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.